Canine Hemangiosarcoma Detection via Serum Thymidine Kinase
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack effective screening mechanisms for early detection of hemangiosarcoma in dogs, a rapidly growing and often internally developing cancer that is difficult to detect due to its internal development and lack of noticeable symptoms until advanced stages, leading to delayed treatment and poor prognosis.
Innovation Solution
A method involving the separation of canine blood into serum and non-serum portions, followed by detection of Thymidine Kinase (TK) levels in the serum, with a threshold of 8 units/liter or greater indicating the presence of hemangiosarcoma, using a centrifuge, detector, and indicator system.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Difficulty of detecting and measuring
If conventional screening methods are used, then the detection process is simple, but the detection capability for internal cancers is insufficient
Solution Approach 1:
The patent uses Thymidine Kinase (TK) as an intermediary biomarker to detect hemangiosarcoma. Instead of directly detecting the tumor, the method detects TK enzyme activity in serum, which is released by tumor cells into the bloodstream. This intermediary approach enables indirect detection of internal cancers through simple blood sampling, resolving the contradiction between detection capability and process complexity
Solution Approach 2:
The patent replaces complex mechanical imaging systems (ultrasound, MRI, CT) with a biochemical detection system. By measuring TK enzyme activity through enzymatic reactions and spectrophotometric detection, the method achieves cancer detection without requiring sophisticated mechanical imaging equipment, thus improving detection capability while reducing device complexity
2Loss of time
If early detection methods are developed, then treatment timing is improved, but the detection mechanism complexity increases
Solution Approach 1:
The detection method utilizes the tumor cells' own metabolic activity (TK enzyme production) as the detection signal. The tumor cells essentially 'self-reveal' their presence by releasing TK into the serum, which can be detected without external intervention beyond blood sampling. This self-service mechanism enables early detection while keeping the detection system relatively simple
Solution Approach 2:
The TK enzyme serves as a temporal intermediary that appears in serum before tumors become clinically apparent. This intermediary biomarker provides an early warning signal that precedes visible tumor growth, enabling early detection without requiring complex real-time monitoring systems
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method demonstrates an approximately 80% sensitivity in detecting canine visceral hemangiosarcoma by quantifying TK activity, providing a valuable tool for earlier disease detection and treatment planning.
Implementation Method 1
separating the quantity of blood into a serum portion and a non-serum portion
Implementation Method 2
contacting the serum portion of the blood with a detector to detect presence of an amount of Thymidine Kinase (TK)
Data Source
AI summary
The disclosure relates to a method for detecting hemangiosarcoma in canines. The method includes the steps of: (1) obtaining a quantity of blood from the subject canine; (2) separating the quantity of blood into a serum portion and a non-serum portion; (3) contacting the serum portion of the blood with a detector to detect presence of an amount of Thymidine Kinase (TK); and (4) detecting the level of TK in serum and determining whether TK is present in amounts of about 8 units/L or greater.